It represents the complete or partial loss of a body extremity, either through elective surgery (surgical/therapeutic amputation) or as the direct result of a traumatic injury (traumatic amputation)
Whilst transdermal patch delivery systems are being explored in research, it is crucial to understand that no GLP-1 patches are currently licensed or approved for use in the UK
*Includes gastroparesis, cholecystitis, cholelithiasis, bowel obstruction, cyclic vomiting, syndrome, gastroenteritis, and pancreatitis
Metabolic and bariatric surgery represents a more definitive intervention for eligible patients with severe obesity who cannot maintain results with pharmacotherapy alone
R., Fink-Jensen, A
Where possible, you should prioritize only using FDA-approved GLP-1 medication